Literature DB >> 16246486

DAPK promotor methylation is an early event in colorectal carcinogenesis.

Falk Mittag1, Doerthe Kuester, Michael Vieth, Brigitte Peters, Bernd Stolte, Albert Roessner, Regine Schneider-Stock.   

Abstract

Death-associated protein kinase (DAPK) is frequently inactivated by promotor hypermethylation in various human cancers. At present, little is known about the significance of DAPK inactivation in colorectal carcinogenesis. We therefore, investigated macrodissected samples of 22 formalin-fixed and paraffin-embedded T1-carcinomas showing normal colon mucosa, intraepithelial neoplasia and carcinoma tissue on the same slice. Dissected carcinoma areas showed a higher frequency of DAPK promotor methylation (81.2%) compared to intraepithelial neoplasia (68.2%). Colon mucosa adjacent to intraepithelial neoplasia or carcinoma showed DAPK promotor methylation in only two of eight cases (25%). We suggest that DAPK promotor hypermethylation may play an important role in the early steps of tumor progression in colorectal carcinoma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16246486     DOI: 10.1016/j.canlet.2005.08.034

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  28 in total

1.  Insights into the role of DNA methylation in disease through the use of mouse models.

Authors:  Melissa Conerly; William M Grady
Journal:  Dis Model Mech       Date:  2010 May-Jun       Impact factor: 5.758

2.  Early involvement of death-associated protein kinase promoter hypermethylation in the carcinogenesis of Barrett's esophageal adenocarcinoma and its association with clinical progression.

Authors:  Doerthe Kuester; Altaf A Dar; Christopher C Moskaluk; Sabine Krueger; Frank Meyer; Roland Hartig; Manfred Stolte; Peter Malfertheiner; Hans Lippert; Albert Roessner; Wael El-Rifai; Regine Schneider-Stock
Journal:  Neoplasia       Date:  2007-03       Impact factor: 5.715

Review 3.  DNA methylation patterns as noninvasive biomarkers and targets of epigenetic therapies in colorectal cancer.

Authors:  Yutaka Hashimoto; Timothy J Zumwalt; Ajay Goel
Journal:  Epigenomics       Date:  2016-04-22       Impact factor: 4.778

4.  Ser289 phosphorylation activates both DAPK1 and DAPK2 but in response to different intracellular signaling pathways.

Authors:  Ruth Shiloh; Shani Bialik; Adi Kimchi
Journal:  Cell Cycle       Date:  2019-05-22       Impact factor: 4.534

5.  Screening for differentially methylated genes among human colorectal cancer tissues and normal mucosa by microarray chip.

Authors:  Wei Chen; Jun Xiang; De-Feng Chen; Bei-Bei Ni; Hao Chen; Xin-Juan Fan; Pu-Ning Wang; Shun-Xin Song; Le-Kun Fang; Huan-Yu Xiao; Lei Wang; Jian-Ping Wang
Journal:  Mol Biol Rep       Date:  2013-03-08       Impact factor: 2.316

6.  Downregulation of DAPK1 promotes the stemness of cancer stem cells and EMT process by activating ZEB1 in colorectal cancer.

Authors:  Wenzheng Yuan; Jintong Ji; Yan Shu; Jinhuang Chen; Sanguang Liu; Liang Wu; Zili Zhou; Zhengyi Liu; Qiang Tang; Xudan Zhang; Xiaogang Shu
Journal:  J Mol Med (Berl)       Date:  2018-11-20       Impact factor: 4.599

7.  Alteration of bone sialoprotein expression in osseous metastasized renal cell carcinomas and the tumor surrounding tissue.

Authors:  F Mittag; J Hennenlotter; L Minkley; I Ipach; D Schilling; M Scharpf; A Stenzl; U Leichtle; T Kluba
Journal:  Clin Exp Metastasis       Date:  2011-12-01       Impact factor: 5.150

8.  DNA methylation in promoter region as biomarkers in prostate cancer.

Authors:  Mihi Yang; Jong Y Park
Journal:  Methods Mol Biol       Date:  2012

9.  Aberrant DNA methylation occurs in colon neoplasms arising in the azoxymethane colon cancer model.

Authors:  Scott C Borinstein; Melissa Conerly; Slavomir Dzieciatkowski; Swati Biswas; M Kay Washington; Patty Trobridge; Steve Henikoff; William M Grady
Journal:  Mol Carcinog       Date:  2010-01       Impact factor: 4.784

10.  Identification of early intestinal neoplasia protein biomarkers using laser capture microdissection and MALDI MS.

Authors:  Baogang J Xu; Jiaqing Li; R Daniel Beauchamp; Yu Shyr; Ming Li; M Kay Washington; Timothy J Yeatman; Robert H Whitehead; Robert J Coffey; Richard M Caprioli
Journal:  Mol Cell Proteomics       Date:  2009-01-21       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.